| Description |
1 online resource |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Note |
Print version record. |
| Contents |
RITUXIMAB: PHARMACOLOGY, CLINICAL USES AND HEALTH EFFECTS; RITUXIMAB: PHARMACOLOGY, CLINICAL USES AND HEALTH EFFECTS; Library of Congress Cataloging-in-Publication Data; Contents; Introduction to Rituximab: The Magic B Cell Bullet; Chapter 1: Rituximab: Pharmacology, Clinical Indications and Health Benefits; Abstract; 1. Introduction: Monoclonal Antibodies as Targeted Therapies; 2. Pharmacological Properties; 3. Efficacy; 3.1. Follicular Lymphoma; 3.1.1. Initial Therapy; 3.1.2. Therapy for Relapsed or Refractory Disease; 3.1.3. Maintenance Therapy; 3.2. Diffuse Large B-Cell Lymphoma. |
|
3.2.1. Initial Therapy3.2.2. Therapy for Relapsed or Refractory Disease; 3.2.3. Maintenance Therapy; 3.3. Chronic lymphocytic Leukemia (CLL); 3.3.1. Initial Therapy; 3.3.2. Relapsed or Refractory Disease; 3.4. Mantle Cell Lymphoma; 4. Tolerability; 5. Cost-Effectiveness and Cost-Utility; Conclusion; References; Chapter 2: Rituximab: Update on Pharmacology and Clinical Applications; Abstract; 1. Introduction; 2. Pharmacology; 2.1. Structure and Mechanisms of Action; 2.2. Pharmacokinetics; 2.3. Absorption; 2.4. Distribution; 2.5. Metabolism and Excretion; 2.6. Dosage and Administration. |
|
2.7. Pharmacogenomics2.9. Drug Interactions; 2.9.1. Other Monoclonal Antibodies; 2.9.2. Disease Modifying Anti-Rheumatic Drugs (DMARD); 2.9.3. Live Viral Vaccines; 2.9.4. Other Drugs; 3. Clinical Uses; 3.1. Neoplasms; 3.2. Autoimmune Conditions; 3.3. Dermatologic Diseases; 3.4. Infectious Conditions; 4. Health Effects; Conclusion; References; Chapter 3: Rituximab in the Treatment of Hematological Malignancies; Abstract; Introduction; Follicular Lymphoma; Single Agent Rituximab in Symptomatic Advanced Stage FL; Rituximab in Combination with Chemotherapy in Advanced Stage Symptomatic Disease. |
|
Rituximab Maintenance in Follicular LymphomaEarly Stage FL; Single Agent Rituximab in Asymptomatic Advanced Stage FL; Safety of Rituximab in Follicular Lymphoma; Novel Treatments and Future Directions in the Treatment of Follicular Lymphoma; Follicular Lymphoma Summary; Other Low Grade Lymphomas; Waldenström Macroglobulinaemia; MALT Lymphoma and Marginal Zone Lymphoma; Hairy Cell Leukemia; Mantle Cell Lymphoma; Diffuse Large B Cell Lymphoma; Relapsed or Refractory DLBCL; DLBCL Summary; Burkitt Lymphoma; Acute Lymphoblastic Leukemia; Chronic Lymphocytic Leukemia; Hodgkin Lymphoma. |
|
Multiple MyelomaSafety and Toxicity of Rituximab in the Treatment of Hematological Malignancies; Allergy and Infusion Reactions; Hematological Toxicity; Infections; Future Directions; Novel Monoclonal Antibodies; Conclusion; References; Chapter 4: The Use of Rituximab in Rheumatoid Arthritis; Rheumatoid Arthritis; Overview of the Management of Rheumatoid Arthritis; The Use of Biological Therapies in Rheumatoid Arthritis; Mechanism of Action of Rituximab in Rheumatoid Arthritis; Key Clinical Trials of Rituximab in Rheumatoid Arthritis; Early Clinical Experience; Phase II Clinical Trial Data. |
| Subject |
Rituximab.
|
|
Rituximab.
|
|
MEDICAL -- Pharmacology.
|
|
Rituximab
|
| Added Author |
Lake-Bakaar, G. V. (Gerry V.), 1948-
|
| Other Form: |
Print version: Rituximab. Hauppauge, N.Y. : Nova Science ; Lancaster : Gazelle [distributor], 2012 9781622575336 (OCoLC)809124211 |
| ISBN |
9781622575473 (electronic bk.) |
|
1622575474 (electronic bk.) |
|
9781622575336 |
|
1622575334 |
| Standard No. |
DEBBG BV041049779 |
|
